Species-specific anticoagulant and mitogenic activities of murine protein S
- 8 October 2009
- journal article
- Published by Ferrata Storti Foundation (Haematologica) in Haematologica
- Vol. 94 (12) , 1721-1731
- https://doi.org/10.3324/haematol.2009.009233
Abstract
Background The protein C pathway down-regulates thrombin generation and promotes cytoprotection during inflammation and stress. In preclinical studies using models of murine injury (e.g., sepsis and ischemic stroke), murine protein S may be required because of restrictive species specificity. Design and Methods We prepared and characterized recombinant murine protein S using novel coagulation assays, immunoassays, and cell proliferation assays. Results Purified murine protein S had good anticoagulant co-factor activity for murine activated protein C, but not for human activated protein C, in mouse or rat plasma. In human plasma, murine protein S was a poor co-factor for murine activated protein C and had no anticoagulant effect with human activated protein C, suggesting protein S species specificity for factor V in addition to activated protein C. We estimated that mouse plasma contains 22±1 μg/mL protein S and developed assays to measure activated protein C co-factor activity of the protein S in murine plasma. Activated protein C-independent anticoagulant activity of murine protein S was demonstrable and quantifiable in mouse plasma, and this activity was enhanced by exogenous murine protein S. Murine protein S promoted the proliferation of mouse and human smooth muscle cells. The potency of murine protein S was higher for mouse cells than for human cells and similarly, human protein S was more potent for human cells than for mouse cells. Conclusions The spectrum of bioactivities of recombinant murine protein S with mouse plasma and smooth muscle cells is similar to that of human protein S. However, in vitro and in vivo studies of the protein C pathway in murine disease models are more appropriately performed using murine protein S. This study extends previous observations regarding the remarkable species specificity of protein S to the mouse.Keywords
This publication has 55 references indexed in Scilit:
- Hyperantithrombotic, noncytoprotective Glu149Ala-activated protein C mutantBlood, 2009
- Plasma protein S contains zinc essential for efficient activated protein C‐independent anticoagulant activity and binding to factor Xa, but not for efficient binding to tissue factor pathway inhibitorThe FASEB Journal, 2009
- Protein S down‐regulates factor Xase activity independent of activated protein C: specific binding of factor VIII(a) to protein S inhibits interactions with factor IXaBritish Journal of Haematology, 2008
- Immunobiology of the TAM receptorsNature Reviews Immunology, 2008
- Re-evaluation of the role of the protein S-C4b binding protein complex in activated protein C-catalyzed factor Va-inactivationBlood, 2008
- Endotoxemia and sepsis mortality reduction by non-anticoagulant–activated protein CThe Journal of Experimental Medicine, 2007
- Prevention of thrombosis following deep arterial injury in rats by bovine activated protein C requiring co-administration of bovine protein SThrombosis and Haemostasis, 2003
- Serum-derived protein S binds to phosphatidylserine and stimulates the phagocytosis of apoptotic cellsNature Immunology, 2002
- The Gene Coding for the β-Chain of C4b-Binding Protein (C4BPB) Has Become a Pseudogene in the MouseGenomics, 1994
- Enhancement of rabbit protein S anticoagulant cofactor activity in vivo by modulation of the protein S C4B binding protein interaction.Journal of Clinical Investigation, 1990